Kidney cancer, Liver cancer, Ovarian cancer, Renal cell cancer, Secondary cancers, Stomach cancer
Results
Phase 2
This study looked at tasquinimod for liver cancer, ovarian cancer, kidney cancer and stomach (gastric) cancer. It was for people whose cancer had come back or spread to another part of the body. This is called .
The study was open for people to join between 2012 and 2014. The team published the results in 2017.
Recruitment start: 1 November 2012
Recruitment end: 31 July 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Ruth Plummer
Experimental Cancer Medicine Centre (ECMC)
Ipsen
NIHR Clinical Research Network: Cancer
Last reviewed: 07 Nov 2023
CRUK internal database number: 10437
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
